SIREN : 830861860
BIOSENCY is a French company founded 8 years ago, specialized in the sector Activités spécialisées, scientifiques et techniques diverses. Based in SAINT-GREGOIRE (35760), this company of category PME shows in 2019 a revenue of 9 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | 9 088 € | N/C |
| Net income | -3 701 792 € | -2 670 397 € | -1 579 698 € | -838 333 € | -571 368 € | -175 779 € |
| EBITDA | N/C | N/C | N/C | N/C | -832 663 € | N/C |
| Net margin | N/C | N/C | N/C | N/C | -6287.1% | N/C |
In 2024, BIOSENCY records a net loss of 3.7 M€. This deficit will reduce equity on the balance sheet.
-3 701 792 €
The debt ratio (= Financial debt / Equity x 100) stands at 163%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 29%. The balance between equity and debt is satisfactory.
162.682%
29.28%
29.0%
In 2024, the debt ratio of BIOSENCY (162.68) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of BIOSENCY (29.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
The liquidity ratio (= Current assets / Current liabilities) stands at 318.78. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
318.778
In 2024, the liquidity ratio of BIOSENCY (318.78) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 273 days. Excellent situation: suppliers finance 273 days of the operating cycle (retail model).
0 €
0 j
273 j
0 j
Compare BIOSENCY with other companies in the same sector:
Voir toutes les statistiques du secteur Activités spécialisées, scientifiques et techniques diverses
The revenue of BIOSENCY in 2019 is 9 k€.
BIOSENCY recorded a net loss in 2024.
The headquarters of BIOSENCY is located in SAINT-GREGOIRE (35760), in the department Ille-et-Vilaine.
The tax return of BIOSENCY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOSENCY operates in the sector Activités spécialisées, scientifiques et techniques diverses (NAF code 74.90B). See the 'Sector positioning' section above to compare the company with its competitors.